Now Accepting Applications: Chair and Professor,
Department of Pharmaceutical Sciences and Experimental Therapeutics (PSET)
Department Faculty
Faculty in Pharmaceutics and Experimental Therapeutics engage in diverse and impactful research spanning toxicology, mitochondrial biology, nanotechnology, gene and transdermal drug delivery, microRNAs, and more. Secondary faculty from the Carver College of Medicine, College of Dentistry, and College of Engineering contribute to this collaborative environment. In addition to their research, faculty teach across undergraduate, graduate, and Doctor of Pharmacy programs.
Graduate Programs
The department offers two dynamic doctoral programs that prepare the next generation of scientists to make meaningful contributions to human health.
- Drug Discovery and Experimental Therapeutics - This PhD program focuses on discovering and developing new therapeutics. Students in medicinal chemistry research innovative methods to create anti-infective, anti-cancer, and anti-viral agents, preparing for careers in academia, industry, and government.
- Pharmaceutics - The Pharmaceutics program trains students to transform new drug entities—from small molecules to proteins and cells—into safe, effective medicines. Graduates are equipped for impactful careers advancing pharmaceutical science and global healthcare.
Research and Funding
By the Numbers
- PSET Faculty as PI have 30 active awards
- 19 Federal and 11 Non-Federal Awards
- 15 NIH Awards - 9 as the prime award and 6 through a subcontract
- Project totals for the 30 awards is $26,106,226
Current Sponsors
- NIH (NCI, NHLBI, NIAID, NIGMS, NIEHS, NIDDK, ARPA-H)
- DOD
- NSF
- US Department of Veterans Affairs
- Roy J. Carver Charitable Trust
- American Heart Association
- Alzheimer's Association
- Gastro-Intestinal Research Foundation
- 6 Industrial Organizations